Featured Research

from universities, journals, and other organizations

Genes Associated With Adverse Reactions To Cancer Radiotherapy Treatment Identified

Date:
April 19, 2007
Source:
University of Leicester
Summary:
Medical scientists have announced a potentially unique advance in breast cancer research by identifying two genes associated with adverse reaction to cancer treatment.

Medical scientists at the University of Leicester have announced a potentially unique advance in breast cancer research by identifying two genes associated with adverse reaction to cancer treatment.

The research could mean people who might react badly to radiotherapy could be warned in advance or alternative treatments be sought. There is no test at present for an abnormal reaction to radiotherapy. No-one in the past has proposed such a test.

The team who carried out the study included Drs Paul Symonds, Mark Plumb, Irene Peat and George Giotopoulos of the Department of Cancer Studies and Molecular Medicine and the Department of Genetics at the University of Leicester. Their results are published in the British Journal of Cancer.

Dr Symonds said: "Radiotherapy is a very important treatment for breast cancer. A small number of people can develop severe side effects."

"During treatment patients can get redness of the skin which may peel off. Later the breast may shrink (atrophy) and the tissues under the skin may become hard and thickened (fibrosis). Red widened blood vessels can appear in the skin (telangiectasia)."

After examining patients at the Glenfield Hospital, Leicester Royal Infirmary and the City Hospital Nottingham, the team at the University of Leicester, funded in part by the Hope Foundation for Cancer Research, has found 2 separate genes strongly associated with either thickening of tissue or red widened blood vessels.

"About 8% of women carry the fibrosis gene and have 15 times the risk of developing thickening of the tissues which is often associated with lifelong chronic pain.

"The genes we have identified at present have a predictive value of 50-60% for the development of marked fibrosis with breast pain. If we could identify the acute genes that lead to marked redness and peeling of the skin, this could increase the predictive value of the test to almost 100%."

Dr Symonds said further work needs to be done as the researchers have not found the genes responsible for redness and peeling of the skin during treatment.

"In the future it may be possible to identify people who are going to react badly to radiotherapy. Such patients should only receive radiation treatment if there is no alternative and be warned of an increased risk of fibrosis," he said.


Story Source:

The above story is based on materials provided by University of Leicester. Note: Materials may be edited for content and length.


Cite This Page:

University of Leicester. "Genes Associated With Adverse Reactions To Cancer Radiotherapy Treatment Identified." ScienceDaily. ScienceDaily, 19 April 2007. <www.sciencedaily.com/releases/2007/04/070419085430.htm>.
University of Leicester. (2007, April 19). Genes Associated With Adverse Reactions To Cancer Radiotherapy Treatment Identified. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2007/04/070419085430.htm
University of Leicester. "Genes Associated With Adverse Reactions To Cancer Radiotherapy Treatment Identified." ScienceDaily. www.sciencedaily.com/releases/2007/04/070419085430.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins